http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0308162-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
filingDate 2003-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ee5908e23ebbed0708b661374da2ca2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b5584aff9d2f61362b26120d964896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_482acaff7309509d43ea53a6fe4f0a24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ed10e8f85a25324591187ac509f77ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85a63efa4a8ba26bda4229b69616eea9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca0e4a5bdf94615f097ebfdd2f2d396
publicationDate 2004-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0308162-A
titleOfInvention Thienopyridine indolyl urea derivatives useful as antiangiogenic agents and methods for their use
abstract "INDOLYL-UREA DERIVATIVES OF USEFUL TIENOPYRIDINES AS ANTIGIOGENIC AGENTS AND METHODS FOR USE". The present invention relates to compounds represented by formula I and to their pharmaceutically acceptable prodrugs, salts or solvates of said compounds or said prodrugs, wherein X, R1 and R11 are as defined herein. . The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.
priorityDate 2002-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421005297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21191320

Total number of triples: 25.